Cutaneous malignant melanoma is a highly aggressive and frequently chemoresistant cancer, the incidence of which continues to rise. Epidemiological studies show that the major aetiological melanoma risk factor is ultraviolet (UV) solar radiation, with the highest risk associated with intermittent burning doses, especially during childhood 1,2 . We have experimentally validated these epidemiological findings using the hepatocyte growth factor/scatter factor transgenic mouse model, which develops lesions in stages highly reminiscent of human melanoma with respect to biological, genetic and aetiological criteria, but only when irradiated as neonatal pups with UVB, not UVA 3,4 . However, the mechanisms underlying UVB-initiated, neonatal-specific melanomagenesis remain largely unknown. Here we introduce a mouse model permitting fluorescence-aided melanocyte imaging and isolation following in vivo UV irradiation. We use expression profiling to show that activated neonatal skin melanocytes isolated following a melanomagenic UVB dose bear a distinct, persistent interferon response signature, including genes associated with immunoevasion. UVB-induced melanocyte activation, characterized by aberrant growth and migration, was abolished by antibodymediated systemic blockade of interferon-c (IFN-c), but not type-I interferons. IFN-c was produced by macrophages recruited to neonatal skin by UVB-induced ligands to the chemokine receptor Ccr2. Admixed recruited skin macrophages enhanced transplanted melanoma growth by inhibiting apoptosis; notably, IFN-c blockade abolished macrophage-enhanced melanoma growth and survival. IFN-c-producing macrophages were also identified in 70% of human melanomas examined. Our data reveal an unanticipated role for IFN-c in promoting melanocytic cell survival/immunoevasion, identifying a novel candidate therapeutic target for a subset of melanoma patients.
Cutaneous malignant melanoma is a highly aggressive and frequently chemoresistant cancer, the incidence of which continues to rise. Epidemiological studies show that the major aetiological melanoma risk factor is ultraviolet (UV) solar radiation, with the highest risk associated with intermittent burning doses, especially during childhood 1, 2 . We have experimentally validated these epidemiological findings using the hepatocyte growth factor/scatter factor transgenic mouse model, which develops lesions in stages highly reminiscent of human melanoma with respect to biological, genetic and aetiological criteria, but only when irradiated as neonatal pups with UVB, not UVA 3, 4 . However, the mechanisms underlying UVB-initiated, neonatal-specific melanomagenesis remain largely unknown. Here we introduce a mouse model permitting fluorescence-aided melanocyte imaging and isolation following in vivo UV irradiation. We use expression profiling to show that activated neonatal skin melanocytes isolated following a melanomagenic UVB dose bear a distinct, persistent interferon response signature, including genes associated with immunoevasion. UVB-induced melanocyte activation, characterized by aberrant growth and migration, was abolished by antibodymediated systemic blockade of interferon-c (IFN-c), but not type-I interferons. IFN-c was produced by macrophages recruited to neonatal skin by UVB-induced ligands to the chemokine receptor Ccr2. Admixed recruited skin macrophages enhanced transplanted melanoma growth by inhibiting apoptosis; notably, IFN-c blockade abolished macrophage-enhanced melanoma growth and survival. IFN-c-producing macrophages were also identified in 70% of human melanomas examined. Our data reveal an unanticipated role for IFN-c in promoting melanocytic cell survival/immunoevasion, identifying a novel candidate therapeutic target for a subset of melanoma patients.
Mechanisms associated with UV-mediated alterations to melanocytes and their microenvironment have been inscrutable because they cannot be adequately studied in cultured cells. Moreover, melanocytes represent only ,1% of skin cells, and bear few specific cell-surface markers permitting efficient isolation. To enable detailed study of melanocyte biology in vivo, we generated a mouse model in which expression of the reverse tetracycline-activated transactivator rtTA2s-M2, characterized by minimal leakiness and background, was regulated by the melanocyte-specific dopachrome tautomerase (Dct) gene promoter ( Supplementary Fig. 1a ). Dct-rtTA mice bred with transgenic mice bearing a histone H2B-GFP fusion construct controlled by the tetracycline response element (TRE) created Dct-rtTA/TRE-H2B-GFP bi-transgenic mice (hereafter iDct-GFP) ( Supplementary Fig. 1b ). iDct-GFP mice showed an inducible GFP profile from embryonic to adult stages consistent with known Dct expression patterns. GFP expression was observed in embryonic neural crest, retinal pigment epithelium and telencephalon, as expected ( Fig. 1a and Supplementary   Fig. 2 ). Neonatal and adult skin GFP 1 cells were strictly localized to hair follicles, where most GFP 1 cells were in bulb regions, with smaller numbers in the outer root sheath and bulge regions, harbouring melanocyte precursors 5 (Fig. 1b ). Co-localization of GFP and anti-Dct antibody by immunohistochemistry unequivocally identified GFP 1 cells as melanocytes ( Fig. 1c ). No background GFP expression was detectable without doxycycline. Full GFP induction was achieved within 12-18 h of a single intraperitoneal injection of a non-toxic doxycycline dose in neonatal or adult mice ( Supplementary Fig. 1c ).
Reasoning that new clues to the molecular mechanism(s) underlying UV-induced melanomagenesis would be found within the genomic response of melanocytes to UV radiation, we used the iDct-GFP mouse to examine the responses to UVB versus UVA of melanocytes residing in situ, within their natural morphological and physiological microenvironment. Precisely defined wideband wavelengths and physiologically relevant doses 4 (see Methods) of UV ( Supplementary  Fig. 3 ) were used to irradiate postnatal day 1 (PD1) iDct-GFP mice, and skins were harvested at certain time points after irradiation. To avoid potential toxicity from chronic expression and interference with UV absorption, GFP was doxycycline-induced after UV irradiation, 24 h before skin harvest. GFP 1 melanocytes were phenotypically activated, characterized by raised melanocyte numbers and migration towards the epidermis as previously reported 6 , 24-48 h after exposure to UVB, but not UVA, peaking at 3 days and lasting at least 10 days after irradiation ( Fig. 1d and Supplementary Fig. 4a ). UVB-induced melanocyte activation was specific to neonatal irradiation; adult mice irradiated at PD29 did not show this response ( Supplementary Fig. 4b ).
We performed an expression microarray study on melanocytes isolated from dorsal skin of iDct-GFP pups irradiated at PD1 with UVB or UVA ( Fig. 1e ). Doxycycline-induced GFP-labelled melanocytes were isolated via fluorescence-activated cell sorting (FACS) at 1 day and 6 days after irradiation (ages PD2 and PD7, respectively); arrays from 1 day post-UV would reflect the acute UV stress response of in vivo melanocytes, whereas the 6 days post-UV time point should uncover responses persisting after the acute stress response subsides. FACS isolation consistently yielded .95% melanocyte enrichment ( Supplementary Fig. 5 ). Gene expression profiling produced robust data with good reproducibility among biological triplicates ( Fig. 2a) , and confirmed the absence of detectable levels of contaminating skin cell types, including keratinocytes, fibroblasts and adipocytes (Supplementary Fig. 6 ).
UVB elicited a potent, transient, acute stress response in melanocytes, including increased expression of p53 target genes (for example, p21 Waf1/Cip1 , cyclin G1 and reprimo), whereas UVA-associated changes were subtle ( Fig. 2a and Supplementary Fig. 7 ). Intriguingly, a small subset of genes showed a delayed response evident at 6 days after UVB exposure ( Fig. 2a ), including a putative IFN-responsive gene signature 7 ( Fig. 2a and Supplementary Table 1 ). Four upregulated genes (Ccl8, Ctla4, H2-K1 and H2-T23) from this group were validated by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) (Fig. 2b) . The response was neonate specific ( Supplementary Fig. 8 ), and included genes implicated in conferring immunoevasiveness (that is, Ctla4, H2-T23, H2-M3, Cfb (also known as H2-Bf) and C4a (also known as Slp)).
To determine whether IFN signalling has a biologically significant role in UVB-induced melanocyte activation, we blocked both type-I (IFN-a and IFN-b) and type-II (IFN-c) interferons by neonatal administration of anti-IFN-a receptor 1 (IFN-aR1) and anti-IFN-c antibodies, respectively. Melanocytes from 6-day post-UVB skin were activated in the presence of isotype control antibody, whereas the anti-IFN-aR11anti-IFN-c antibody combination completely abolished this response ( Fig. 2c ). Moreover, although antibody-mediated blockade of type-I IFN-a/b signalling alone failed to overtly affect UVBmediated activation, blockade of IFN-c alone markedly inhibited this response ( Fig. 2c ). These results were corroborated by flow cytometric quantification of GFP 1 skin cells from each antibody-treated group ( Supplementary Fig. 9 ). We next isolated GFP 1 melanocytes from UV-irradiated neonates blocked with either anti-IFN-c or anti-IFN-aR1, and compared their expression patterns to control. Anti-IFN-c and anti-IFN-aR1 antibodies repressed expression of a common gene set associated with the IFN response ( Supplementary Fig. 10 ). However, IFN-c inhibition also more potently repressed expression of several non-classical major histocompatibility complex (MHC) class Ib antigens (for example, H2-T23 and H2-Q2), as well as Psmb9, Gbp2, Icam, Irf1 and Fosb; members of this gene subset should be responsible for the observed melanocytic phenotypes. Notably, IFN-c blockade exclusively and potently inhibited expression of chemokine Ccl8 (also known as MCP-2).
We determined the IFN-c source by interrogating 6-day post-UVBirradiated skin for immune-cell infiltration. Immunohistochemistry failed to detect T cells, B cells, dendritic cells, natural killer (NK), or NK-T cells; however, CD11b 1 cells of myeloid origin were evident ( Supplementary Fig. 11 ). Anti-F4/80 and anti-Gr-1 antibodies identified these as macrophages (F4/80 1 Gr-1 2 ), not neutrophils ( Fig. 3a , upper panel). Nearly 90% of CD11b 1 cells were also F4/80 1 ( Supplementary Fig. 12 ). Notably, the adult response was distinct; dorsal skins from PD35 mice 2 days after UVB showed predominant Gr-1 1 cell infiltration, and minimal F4/80 1 cells ( Fig. 3a , lower panel), as reported 8 .
To determine if infiltrating macrophages expressed IFN-c, as has been suggested 9 , type-I and type-II interferon mRNAs were quantified from FACS-purified CD11b 1 and F4/80 1 cells. Both had upregulated IFN-a and IFN-c expression, and to a lesser extent IFN-b ( Fig. 3b ). Flow cytometry demonstrated that 28% of both CD11b 1 and F4/80 1 cells expressed IFN-c ( Fig. 3c ). Our data support the notion that UVBrecruited, infiltrating macrophages secrete IFN-c, inducing the IFN signature detected in activated melanocytes. Although we were unable to detect NK cell markers in FACS-isolated CD11b 1 cells by qRT-PCR ( Supplementary Fig. 13 ), we cannot rule out a possible contribution by undetectably low numbers of NK or other inflammatory cells.
That UVB-induced chemokines were responsible for neonatal macrophage recruitment, particularly Ccr2/Ccr5 ligands, was indicated by our melanocyte microarray data and confirmed by qRT-PCR ( Supplementary Fig. 14a, b) . These results were further corroborated through treatment of cultured melan-c normal immortalized melanocyte cell line with non-cytocidal UV ( Supplementary Fig. 14c ). In contrast, upregulation of these chemokines was not detected in UV-irradiated whole skin ( Supplementary Fig. 15 ) or isolated keratinocytes 10 . Ccr2 and Ccr5 were highly expressed in skin-infiltrating macrophages, but not in non-activated RAW264.7 macrophages ( Supplementary Fig. 16 ). Finally, mice deficient in Ccr2 were significantly inhibited in their ability to recruit F4/80 1 macrophages into neonatal skin ( Fig. 3d ); in contrast, Ccr5-deficient mice showed no significant difference (data not shown).
The arrival of IFN-c-expressing macrophages coincided with a .100-fold upregulation in melanocyte expression of the Ccr2 ligand Ccl8, a known IFN-c-response gene 11 , whereas expression of other Ccr2 ligands had returned to baseline. We propose that recruited IFN-c 1 macrophages enhance melanocyte Ccl8 expression, reinforcing macrophage-melanocyte interactions and fueling an inflammatory positive feedback loop. To confirm its ability to potently chemoattract macrophages, Ccl8 was ectopically expressed in F5061 cells-established from a UV-induced melanoma from an immunocompetent hepatocyte 
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growth factor/scatter factor (HGF/SF)-transgenic mouse. F5061-Ccl8 cells were subcutaneously inoculated into syngeneic FVB/N mice, markedly enhancing macrophage infiltration into the transplantation site ( Fig. 3e ). Conditioned media from F5061-Ccl8 cells also significantly elevated transmembrane migration of RAW264.7 macrophages ( Supplementary Fig. 17 ).
Macrophages show either anti-or pro-tumorigenic properties 12 . F4/ 80 1 macrophages were isolated from 6-day post-UVB neonatal skin, admixed at a ratio of 1:5 with F5061 melanoma cells and transplanted subcutaneously into FVB/N mice. Admixed transplants showed significantly increased growth relative to controls ( Fig. 4a and Supplementary Fig. 18 ), indicating that these activated macrophages were pro-tumorigenic. In contrast, macrophages isolated from spleens of unirradiated control pups did not affect tumour growth (Supplementary Fig. 19 ). K i -67 immunohistochemistry showed no difference in proliferation between admixed tumours versus controls (Supplementary Fig. 20) ; however, TdT-mediated dUTP nick end labelling (TUNEL) assays revealed significantly less apoptosis in admixed tumours ( Fig. 4b and Supplementary Fig. 21 ), demonstrating that UVB-recruited macrophages promote melanoma cell survival. Immunohistochemistry confirmed that a subset of tumour-associated macrophages maintained IFN-c expression ( Supplementary Fig. 22 ). Moreover, macrophage presence strongly correlated with enhanced Ctla4 expression in F5061 melanoma cells ( Supplementary Fig. 23 ), recapitulating the functional consequence of macrophage infiltration observed in neonatal skin melanocytes ( Fig. 2a, b) .
Despite its well-documented anti-tumorigenic activity 13 , IFN-c has also been implicated as a pro-tumorigenic factor 14, 15 . To determine if macrophage-secreted IFN-c was responsible for the enhanced melanoma growth observed in admixed tumours, we included intraperitoneal administration of either anti-IFN-c or control antibodies. Whereas admixed melanomas in the control group showed the expected enhanced growth, those in mice given anti-IFN-c antibody showed significantly reduced growth (Fig. 4c ). Immunophenotyping of tissue microarrays containing UVB-induced mouse melanomas showed that most (66%) were macrophage-rich, with fewer having T cells (59%) and B cells (32%) 
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( Supplementary Fig. 24 ). To determine if human melanoma-associated macrophages produce IFN-c, we performed dual immunohistochemistry for CD68 and IFN-c using human melanoma tissue microarrays. We discovered that 19 of 27 (70%) melanomas examined contained abundant macrophages (CD68 1 ), of which all 19 demonstrated CD68 1 IFN-c 1 dual positivity ( Fig. 4d and Supplementary  Fig. 25 ).
In this study we show that UV incites melanomagenesis not only through DNA mutagenesis, but also by altering interactions between melanocytes and their microenvironment to regulate remodelling of UV-damaged skin. On the basis of our results, a model implicating a neonatal-specific UV-induced pro-melanomagenic inflammatory cascade emerges (Fig. 4e ). In accordance with their relative tumorigenicity in albino HGF/SF-transgenic mice 4 , UVB not UVA induces melanocytic expression of multiple chemoattracting Ccr2 ligands (Ccl2, Ccl7, Ccl8, Ccl12), recruiting Ccr2 1 macrophages into neonatal skin. IFN-c from recruited macrophages stimulates melanocyte proliferation and migration, and the expression of genes implicated in immunoevasion/survival. Erythemal neonatal UVB causes robust macrophage infiltration and is melanomagenic; adult skin responds with a rapid, short-lived neutrophil influx, but no melanoma. We propose that mechanisms underlying neonatal UVB-induced melanomagenesis operate within the immunoediting paradigm 13 : UVB-activated mutant neonatal melanocytesparticularly progenitors 16 -exposed to inflammation evade immunemediated elimination, persisting through an extended equilibrium phase before evolving into clinically significant melanoma. Macrophageinduced melanocyte proliferation would more efficiently fix UVinduced mutations in prospective melanoma cells, whereas enhanced melanocyte migration could facilitate UVB-associated long-term tolerance to melanocytic antigens 17 by promoting aberrant melanocyteimmune-cell interactions. Moreover, enduring inflammation-associated epigenetic alterations occur in transformed cells 18 , and perhaps in longlived macrophage subpopulations 19 , indefinitely extending their biological effects.
Notably, our systemic antibody blockade experiments demonstrating the importance of physiologically relevant IFN-c in UVB-induced melanocyte activation and melanoma cell survival strongly support the macrophages. PE, phycoerythrin. d, Flow cytometric analysis of macrophage (F4/80 1 ) infiltration into skin, 2 days after UVB irradiation in Ccr2-deficient pups (irradiated at PD1), as compared to wild-type pups. **P , 0.01; one-way ANOVA test with post-hoc Tukey analysis. NS, not significant. e, F5061 melanoma cells ectopically expressing Ccl8 chemoattract F4/80 1 macrophages (red), but not Gr-1 1 cells, to sites of subcutaneous inoculation in syngeneic FVB/N mice. One vector-transfected and two Ccl8-transfected clone cells were used. Blue, DAPI.
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notion that IFN-c can be pro-tumorigenic as well as anti-tumorigenic, depending on the context, intensity and durability of the IFN-c signal 14 . In fact, an association between IFN-c-induced genes and early mouse melanocytic lesions has been reported 15 , and serum IFN-c has been implicated as an independent prognostic indicator for melanoma recurrence 20 . We propose that IFN-c-associated survival mechanisms operational in neonatal melanocytes are recapitulated in melanoma, contributing to the selection of more aggressive, therapeutically resistant phenotypes. Relevance to human melanoma is supported by the detection of macrophage-associated IFN-c expression in most patient samples examined, and a clinical trial showing that IFN-c may have adverse effects regarding melanoma patient relapse and mortality 21 . We provide the first evidence, to our knowledge, that IFN-c-R signalling can facilitate melanoma progression, a remarkable discovery considering that high-dose IFN-a is used to treat melanoma, albeit with limited success 22 . Non-overlapping functions of type-I and type-II interferons are well described 13 , and strongly supported by our data.
The IFN 'survival signature' associated with UVB-activated mouse melanocytes contains genes involved in human melanoma immunoevasion, including non-classical MHC class Ib antigens (mouse H2-M3/human HLA-G; mouse H2-T23 (also known as Qa-1)/human HLA-E) 23, 24 . HLA-E suppresses NK and cytotoxic T lymphocytes 25, 26 . This IFN signature also features complement isoforms C4a and C4b, implicated in systemic autoimmunity suppression 27 , and CTLA4, a potent immune evasion facilitator. CTLA4 is also highly upregulated in mouse melanoma cells admixed with neonatal macrophages, and expressed on human melanoma cells, where it may be involved in immune escape 28, 29 .
Here we identify novel cellular/molecular inflammatory mechanisms centred on IFN-c signalling that may underlie the initiation, survival and/or outgrowth of UVB-induced melanoma cells. We propose that such mechanisms are highly relevant to strategies used by melanoma cells to evade immunosurveillance in patients. In what could prove to be a paradigm shift, our data strongly suggest that IFN-c/IFN-c-R or its downstream pathway members represent promising prognostic markers and/or efficacious therapeutic targets in an appropriate subset of melanoma patients. (1); that activate CCR2 1 macrophages (2); which are recruited to neonatal skin (3); macrophages secrete IFN-c (4); which activates melanocytes, inducing expression of genes that include CCL8, fueling inflammation (5); and immunoevasion (6) .
METHODS SUMMARY
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with the TRE-H2B-GFP transgenic mice, and screened for a line that produced no leaky background expression of GFP without doxycycline and quickly responded to a single intraperitoneal doxycycline injection. One such line was selected to make a double homozygous Dct-rtTA/TRE-H2B-GFP transgenic mouse line in albino FVB/N background, and males were crossed with wild-type FVB/N females to produce litters that were 100% double heterozygous (iDct-GFP). One day after birth, the pups were irradiated with UV radiation (UVB, UVA, or sham) 4 ( Supplementary Fig. 3 ). Dorsal skins were harvested at 24 h and 6 days after irradiation (or sham irradiation). Twenty-four hours before mice were killed and dorsal skins harvested, neonates were injected intraperitoneally with doxycycline at 80 mg g 21 body weight to activate GFP expression. Skins from 6-8 pups of a litter were pooled to prepare single-cell suspensions using a published protocol 30 , followed by isolation of GFP 1 melanocytes via FACS. RNA samples isolated from these melanocytes were subjected to cDNA microarray on Illumina Murine Beadchips v. 2.0 (Illumina). qRT-PCR validation was performed using primers listed in Supplementary Table 2 . Immunohistochemical and flow cytometric analyses were performed using antibodies listed in Supplementary Table 3 .
METHODS
Generation of Dct-rtTA and iDct-GFP mice. DNA fragments from the following plasmids were used to construct the plasmid pDct-rtTA-bGlo, which harbours the transgene fragment used to make the Dct-rtTA transgenic mice. Firstly, phbGlobin: the vector backbone is pBluescript II KS1 and the insert is a BamHI/PstI genomic fragment from the human b-globin gene, which is comprised of partial exon 2, full intron 2, full exon 3 and poly A signal. Secondly, pPDct: this plasmid contains the 3.4-kb BamHI/Eco47III fragment from the Dct gene promoter 31 . Thirdly, pBS/IRES-M2: this plasmid contains the rtTA2s-M2 fragment. It is a variant of pUHrT62-1 32 , and was obtained from C. Toniatti and H. Bujard. The Dct-rtTA transgenic mice were generated using standard microinjection techniques in a FVB/N background strain. Dct-rtTA mice were bred with the TRE-H2B-GFP transgenic mice 33 to generate the bi-transgenic iDct-GFP mice.
Mice. Wild-type FVB/N female breeders, Ccr2 2/2 mice (strain B6.129S4-Ccr2 tm1Ifc /J), and Ccr5 2/2 mice (strain B6.129P2-Ccr5 tm1Kuz /J) were obtained from Jackson Laboratories and housed under the strict guidelines of the Institutional Animal Care and Use Committee (IACUC)-approved protocols. Transportation of mice between National Cancer Institute-Frederick and George Washington University Medical Center (GWUMC) animal facilities was performed by special animal courier service approved by IACUC.
In vivo UV irradiation. iDct-GFP pups were irradiated with UV radiation (UVB, UVA, or sham) as previously described 4 ( Supplementary Fig. 3 ). The standard erythemal dose (SED) is used to compare the sunburning effectiveness of different UV-emitting sources. These sources include UV-emitting lamps in suntanning beds, welder's arcs and sunlight among others. By determining the SED one is able to compare how efficient the UV-emitting sources are at inducing sunburn or reddening in skin relative to each other. In experimental UV studies, many laboratories use different types of UV sources for a variety of experiments. Thus, determining the SED allows one to produce equivalent amounts of 'sunburning' radiation regardless of the UV spectral output of the different sources used. The SED is produced by multiplying the spectral output or irradiance (W m 22 of the UV-emitting source) with the Commission Internationale de l'Eclairage (CIE) standard erythemal action spectrum (note that 1 W 5 1 J s 21 ). The CIE standard erythemal action spectrum is thus used to 'weight' the incoming UV radiation on an erythemal wavelength basis. The product curve produced from this convolution will give the 'erythemal effective' irradiance (W erythemal effective m 22 ) upon integration of the area under this curve. The erythemal effective irradiance is used to calculate the erythemal or sunburning dose by the equation: dose erythemal effective 5 irradiance erythemal effective 3 time (s). By definition, 1 SED 5 100 J m 22 . Thus, our UVB source, which consists of a UVB bandpass interference filter with a half-band width of 65 nm (dimensions: 5.1 cm 3 5.1 cm) blocked to 10 23 to 10 24 outside the main bandpass (280-320 nm). This custom-made filter when coupled to our 2.5 kW Xenon arc allows for very clean wavelength resolution. The 100 cm 2 exposure area is large enough to accommodate up to 12 neonates (1-3 days old), which are situated in a three-chambered animal holder covered with a quartz lid that allows for UV transmission. Holes are drilled into the sides to allow for air exchange. This unit sits on top of a turntable rotating at approximately 3 r.p.m. to average out beam uniformity. The irradiance is measured with a spectroradiometer (StellarNet) and under standard conditions regularly produces an irradiance of approximately 0.30 CIE-effective W m 22 . The exposure time is constant at 90 min. These conditions regularly produce a CIE-effective dose of approximately 14-16 SED. This level of CIE-effective irradiance agrees well with our previous calculations using a radiation transfer algorithm over a global latitude/longitude grid at Northern or Southern summer mid-latitudes 34 . Direct terrestrial measurements at these latitudes indicate that under summer sunlight conditions on clear days in the Northern or Southern Hemisphere between 11:00 and 15:00 local time one can measure SEDs in the range of 10 to 20 depending on exposure conditions. As an example and as part of a project to estimate the number of SEDs one might receive during the day using, in this case, cyclists training in Spain during summer and winter, a recent paper shows just such levels in good agreement with our measurements 35 . FACS. Single-cell suspensions from pooled skin samples were prepared using a published protocol 30 . FACS was performed on a FACSAria flow cytometer (BD Biosciences) equipped with a fixed-alignment cuvette flow cell and a Coherent Sapphire solid state laser providing 13 mW of 488-nm excitation wavelength. Processing rates averaged about 5,000 events per second at 20 psi. Cells of interest were gated by a combination of forward and orthogonal light scatter, and GFP fluorescence was captured in the detector with a 530/30 bandpass filter. GFPpositive cells suspended in PBS plus 1% bovine serum albumin (BSA) were sorted as bulk populations into 12 3 75 mm polypropylene tubes. Dorsal skins from a combined litter of 6-8 pups gave a disaggregated cell suspension containing about 30-50 3 10 6 cells. FACS resulted in collection of 1-3 3 10 5 GFP-positive melanocytes per litter. Following FACS collection of cells into PBS plus 1% BSA solution, the cells were centrifuged at 4 uC, and the pelleted cells were lysed in Trizol Reagent (Invitrogen) for isolation of RNA. Total RNA was isolated from cells by Trizol organic extraction followed by RNeasy Micro Kit (Qiagen Sciences) procedure. Skin macrophages were isolated by immunostaining with anti-F4/80-Alexa Fluor 647 antibody (BioLegend) Microarray analysis of gene expression. Three biological replicates for each group were used for cDNA microarray analyses. RNA was quantified fluorimetrically and assayed for integrity using the Agilent Bioanalyser (Agilent Technologies). Onehundred nanograms of RNA was converted to biotinylated cRNA using one round of amplification with the Illumina Labelling Kit (Illumina) and one round of T7 polymerase amplification and hybridized to Illumina Murine Beadchips v. 2.0. After hybridization and staining, the arrays were scanned in an Illumina Bead Station, and the images processed using Illumina Bead Studio software. Statistical analysis of microarray data. The raw microarray data were extracted from the BeadStudio software and imported into the R statistical programming environment (R Development Core Team) 36 and Bioconductor 37 . A variance stabilization transformation 38 followed by quantile normalization and quality assessment were performed using the lumi package 38 . Differential expression between groups was calculated using a linear model and empirical Bayes-moderated false discovery rates (FDR) for each treated versus untreated line were calculated using the limma package 39 . A heatmap including probes showing differential expression between UVB-treated and untreated with a FDR of 0.05 was generated ( Fig. 2a and Supplementary Fig. 7) . Hierarchical clustering of genes was performed using single linkage and Pearson correlation distance metric. Samples were simply ordered naturally. qRT-PCR. The most highly significant genes identified through the statistical analysis of microarray data were validated by qRT-PCR. Reverse transcription was performed on 0.1-1.0 mg RNA with Superscript III RT system (Invitrogen) following the manufacturer's protocol. Real-time PCR was performed with Quantitect SYBR Green PCR system (Qiagen Sciences) on a 7900HT Real-Time PCR machine (Applied Biosystems). 18S ribosomal RNA was used as the normalizer. The primers used in qRT-PCR are listed in Supplementary Table 2 . Histology and immunohistochemistry. Skin and tumour samples were preserved in optimal cutting temperature (OCT) compound and stored frozen at 280 uC. Fivemicrometre sections were cut using a cryostat (Leica Microsystems) and were observed under a fluorescence microscope (Nikon Instruments) with DAPI (Vectashield, Vector Laboratories) counterstaining. The antibodies for fluorescence immunohistochemistry were obtained as listed in Supplementary Table 3 . Haematoxylin and eosin stainings were performed using standard protocols. Select haematoxylin and eosin stained sections are shown in Supplementary Figure 26 . In vivo antibody-mediated blockade. For the IFN-blockade experiment in pups, the anti-murine IFN-c neutralizing antibody was the rat IgG clone XMG-6 (3.19 mg ml 21 ) 40 . The anti-murine IFN-aR1 antibody was the mouse IgG1 clone MARI-5A3 (purified monoclonal antibodies, 4 mg ml 21 ) 41 . The control antibodies were rat IgG1 clone GL113 (1.52 mg ml 21 ) ascites. The in vivo applications of these antibodies have been described 42, 43 . 0.1-0.2 mg antibody was injected per pup intraperitoneally, 1-2 h before and 3 days after UVB irradiation. For IFN-c blockade in the tumorigenesis experiment, the anti-IFN-c antibody was XMG-6. The control antibody was rat IgG1 against horseradish peroxidase (HRPN; BioXcell). Antibodies were administered intraperitoneally as follows: 1 mg per mouse on days 21, 0, 1, 3, 6; and 0.5 mg per mouse on days 9, 12, and 15 after inoculation. Tumours were harvested at day 18. Immunofluorescence flow cytometry and FACS. The immunofluorescencebased flow cytometry and FACS sorting were done using antibodies listed in Supplementary Table 3 , using standard procedures. In vitro UV irradiation. The melan-c melanocyte cell line (gift from V. Hearing) was irradiated with the Junggust Box, a hand-made enclosed module that houses two F20 sunlamps outputting 60% UVB and 38% UVA wavebands. A total UV dose of 175 J m 22 was given at a dose rate of 2.0 W m 22 . The cells were irradiated in 10-cm culture dishes at 80% confluence overlaid with 3 ml PBS and the dish covered with plastic saran wrap to filter out any UVC. Following irradiation, the cells were incubated for the desired time in normal media (RPMI1640, 10% FBS, 100,000 U l 21 penicillin, 100 mg l 21 streptomycin sulphate, 2 mM glutamine and 200 nM 12-O-tetradecanoylphorbol-13-acetate (TPA)). Chemotactic assays for Ccl8. The cDNA for mouse Ccl8 was amplified by RT-PCR and cloned into the pcDNA3.1 expression vector (Clontech). F5061 cells were transfected using FuGene HD (Roche). Empty pcDNA3.1 vector was transfected as control. In vitro chemotactic assay was performed on the RAW264.7 macrophage cell line in a Transwell system with 8-mm pore size (Corning). 1 3 10 5 cells were seeded in the top well, and the migrant cells were counted following haematoxylin staining. The experiment was done in duplicate. Five random microscopic fields from each replicate were counted for the number of migrant cells. For the in vivo chemotactic assay, 2.5 3 10 5 F5061-Ccl8 or F5061-vector cells were inoculated RESEARCH LETTER subcutaneously in syngeneic FVB/N mice. Skin samples from the area of the inoculation were harvested two days after inoculation, preserved in OCT compound, cryosectioned, and immunohistochemistry with anti-F4/80 antibody was performed to assess macrophage infiltration. Tumorigenicity assay. F4/80 1 macrophages were FACS-isolated from dorsal skins of pups 6 days after UVB irradiation at PD1. Macrophages were admixed with F5061 melanoma cells at a 1:5 ratio (0.5 3 10 5 macrophages: 2.5 3 10 5 F5061) and inoculated subcutaneously in syngeneic FVB/N mice (n 5 10). Control mice were inoculated with 2.5 3 10 5 F5061 cells without macrophages (n 5 10). Tumours were harvested after three weeks and were measured in three dimensions. Tumour volumes were calculated by the formula: V 5 length 3 width 3 depth 3 p 3 1/6. For the tumorigenicity experiment with IFN-c blockade, for each of the two groups with macrophages, four mice had 0.5 3 10 5 macrophages but another 6 mice from each group had 0.42 3 10 5 macrophages mixed with 2.5 3 10 5 F5061 cells. No differences in tumour growth were detected between the mice with these differing numbers of macrophages. All four groups contained ten mice, but two mice from the F5061 plus control-antibody group died prematurely and were taken out of the analysis. TUNEL assay. The TUNEL assay was performed using TACS TdT Fluorescein kit (R&D Systems) following the manufacturer's protocol. Human and mouse melanoma tissue microarrays. The human melanoma tissue microarray was obtained from S. Hewitt at the National Cancer Institute/National Institutes of Health. Antigen retrieval was performed by microwave boiling in citrate buffer (pH 6). Immunohistochemistry with anti-CD68 and anti-IFN-c antibodies (Supplementary Table 3 ) was performed serially with appropriate fluorescencetagged secondary antibodies. The mouse melanoma tissue microarray has been generated by our laboratory and contains melanoma tissues from our HGF/SF transgenic mouse model, induced by a single neonatal UV radiation dose. Anti-F4/80 (macrophages), anti-CD3 (pan T cells) and anti-B220 (B cells) antibodies were used in conjunction with the Vectastain Elite ABC system (Vector Laboratories) following the manufacturer's protocol. Statistical analyses. All statistical analyses were performed using Graphpad Prism software. Two-tailed Student's t-test and ANOVA with post-hoc Tukey analyses were performed as indicated to validate significant differences. Means 6 s.e.m. are indicated for all statistical analyses. A P value of ,0.05 was considered statistically significant.
